Inventiva (IVA) Payables (2018 - 2025)
Inventiva (IVA) posted quarterly Payables of $30.3 million for Q4 2025, down 99.52% year-over-year from $6.3 billion in Q4 2024, and down 99.93% quarter-over-quarter from $45.5 billion in Q2 2025.
Analysis
Inventiva (IVA) Payables (2018 - 2025) Analysis & Trends
Inventiva's Payables history runs 8 years deep, the most recent figure standing at $30.3 million for Q4 2025.
- In Q4 2025, Payables fell 99.52% year-over-year to $30.3 million; the TTM figure through Dec 2025 stood at $30.3 million (down 99.52% YoY), while the FY2025 annual figure was $30.3 million, down 99.52% from the prior year.
- Payables for Q4 2025 stood at $30.3 million, down from $45.5 billion in the prior quarter.
- The five-year high for Payables was $45.5 billion in Q2 2025, with the low at $10.4 million in Q4 2023.
- The 5-year median for Payables is $39.1 million (2023), against an average of $6.2 billion.
- The sharpest annual moves came in 2022 and 2023: Payables soared 167981.2% in 2022, then tumbled 99.82% in 2023.
- Inventiva's Payables stood at $1.5 billion in 2021, then tumbled by 98.67% to $19.8 million in 2022, then surged by 105.26% to $40.5 million in 2023, then jumped by 15453.97% to $6.3 billion in 2024, then slumped by 99.52% to $30.3 million in 2025.
- Business Quant data shows IVA's Payables at $30.3 million in Q4 2025, $45.5 billion in Q2 2025, and $6.3 billion in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 167.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 88.42 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 470.30 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 35.57 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Inventiva | 893.85 Mn | 893.85 Mn | - | 30.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 30.28 Mn |
| Jun 30, 2025 | 87.11 Mn |
| Dec 31, 2024 | 139.53 Mn |
| Jun 30, 2024 | 14.62 Mn |
| Dec 31, 2023 | 55.14 Mn |
| Jun 30, 2023 | 40.23 Mn |
| Dec 31, 2022 | 29.83 Mn |
| Jun 30, 2022 | 15.21 Mn |
| Dec 31, 2021 | 16.70 Mn |
| Jun 30, 2021 | 12.27 Mn |
| Mar 31, 2021 | 10.48 Mn |
| Dec 31, 2020 | 8.28 Mn |
| Jun 30, 2020 | 9.39 Mn |
| Dec 31, 2019 | 8.42 Mn |
| Dec 31, 2018 | 9.73 Mn |